Bonovate Tablet
Dalbergia sissoo (Shisham) 400 mg + Cissus quadrangularis Tablets — Premium Ayurvedic Bone Healing
| Composition | Dalbergia sissoo (Shisham) Extract 400 mg + Cissus quadrangularis Extract |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Alu-Alu Blister |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 2750 |
| Therapy | G.P. + Orthopaedics + Gynaecology — Ayurvedic Bone & Joint Support — Premium |
| Storage | Store below 30 °C in a dry place, away from direct sunlight. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Bonovate Tablet
Bonovate Tablet combines two of Ayurveda’s most studied bone-and-joint herbs: Dalbergia sissoo (Shisham) 400 mg with Cissus quadrangularis (Hadjod) extract. Both have documented in-vivo and clinical evidence supporting their use in fracture healing, osteoporosis and joint health.
Cissus quadrangularis (‘Hadjod’ or ‘bone-setter’) has been used in Ayurveda for over a thousand years for fracture healing. Modern studies show it promotes osteoblast activity, accelerates fracture callus formation and reduces fracture-site pain. Dalbergia sissoo extract contains polyphenols and isoflavones that act on bone-resorption pathways and have shown anti-osteoporotic effects in animal models.
Bonovate is manufactured by Trumac Healthcare in Ayush-compliant facilities under WHO-GMP standards. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a premium high-margin orthopaedic herbal SKU.
Indications
- Fracture healing — adjunctive therapy in conservative and post-surgical care
- Osteoporosis and osteopenia — bone-strengthening adjunct
- Osteoarthritis with joint stiffness and weakness
- Post-menopausal bone loss support
- Bone metabolic disorders requiring herbal support
Mechanism of Action
Cissus quadrangularis contains ketosterols and triterpenes that stimulate osteoblast proliferation and differentiation, accelerate fracture callus formation, and modulate inflammatory cytokines in bone microenvironment. Dalbergia sissoo isoflavones and polyphenols inhibit osteoclast activity and have weak phytoestrogen action supportive of bone density in post-menopausal women.
Dosage & Administration
Adults: 1 tablet twice daily after meals for 6–12 weeks in fracture healing; long-term use possible in chronic osteoporosis and osteoarthritis under physician advice.
Side Effects
Generally well tolerated. Possible mild GI upset, occasional gas/bloating. Rare hypersensitivity reactions.
Contraindications & Precautions
Hypersensitivity to any component. Caution in pregnancy and lactation. Avoid concurrent unsupervised mega-dose calcium or vitamin D supplementation.
Storage
Store below 30 °C in a dry place, away from direct sunlight.
Bonovate Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Bonovate Tablet used for?
Bonovate combines Shisham and Cissus quadrangularis (Hadjod) extracts — used for fracture healing, osteoporosis, osteoarthritis and post-menopausal bone support.
How does Cissus quadrangularis help in fractures?
Cissus quadrangularis ('Hadjod') has been used in Ayurveda for centuries for bone-setting. Modern studies show it stimulates osteoblast activity, accelerates fracture callus formation and reduces fracture-site pain.
Is Bonovate available for PCD pharma franchise?
Yes, Trumac Healthcare offers Bonovate Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing — a premium orthopaedic herbal SKU.
How should Bonovate Tablet be stored?
Store below 30 °C in a dry place, away from direct sunlight.
Is Bonovate Ayush certified?
Yes, manufactured in Ayush-compliant facilities under WHO-GMP standards.
Related Products
- Bonefill Bone Strength Capsule — Ayurvedic Herbal Bone & Joint Support Capsules
- Bonefill Bone Syrup — Ayurvedic Herbal Bone & Joint Tonic Syrup
- Calcirut Tablet — Calcium Citrate 1000 mg + Calcitriol 0.25 mcg + Magnesium